ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.530
-0.035 (-2.24%)
At close: Jun 26, 2026, 4:00 PM EDT
1.559
+0.029 (1.87%)
After-hours: Jun 26, 2026, 7:29 PM EDT
ProQR Therapeutics Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, ProQR Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $8.13. The average 1-year stock price forecast is 431.37% higher than the current stock price, while the lowest is $3.00 (+96.08%) and the highest is $12 (+684.31%).
Price Target: $8.13 (+431.37%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ProQR Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Buy Reiterates $4 → $3 | Buy | Reiterates | $4 → $3 | +96.08% | Jun 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +684.31% | May 13, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $8 | Buy | Maintains | $8 | +422.88% | Apr 15, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $9 | Buy | Reiterates | $9 | +488.24% | Apr 9, 2026 |
| Citizens JMP | Citizens JMP | Buy Reiterates $8 | Buy | Reiterates | $8 | +422.88% | Mar 12, 2026 |
Financial Forecast
Revenue This Year
13.43M
from 16.35M
Decreased by -17.86%
Revenue Next Year
14.37M
from 13.43M
Increased by 7.03%
EPS This Year
-0.53
EPS Next Year
-0.59
from -0.53
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.8M | ||
| Avg | 13.4M | ||
| Low | 2.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.9% | ||
| Avg | -17.9% | ||
| Low | -87.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.53 | ||
| Avg | -0.53 | ||
| Low | -0.53 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |